Following the appointment last week of a new marketing director,
Novartis is planning to review its global creative and PR roster of
The pharmaceuticals and foods company, which owns brands including
Ovaltine, Nicotinell, Isostar and Tixylix, is planning to bring its
agency arrangements in line with its strategy of creating strong global
It is looking to work with a smaller number of agencies that have global
Novartis has different agencies for different jurisdictions but uses
Euro RSCG Life, Grey Worldwide, Rainey Kelly Campbell Roalfe/Y&R and
Lowe Lintas in the UK. The account is worth £6.7 million in the UK
There will be a number of pitches but the company has not confirmed if
this will lead to consolidation of the roster.
However, Novartis is in the process of consolidating its media agencies
in the US. The CIA network, which handles the UK task, is competing with
MindShare and Initiative Media. The media task will still be run on a
country-by-country basis but the winning agency will take the lead role
Earlier this month Novartis consolidated its top two marketing roles
into one with the appointment of Nick Evans, the former Boots skincare
marketer, to the position of marketing director for consumer
Evans will control the marketing of all Novartis consumer products.
Novartis is looking to bring consistency to its marketing of products
globally. It plans to follow the example of companies such as Coca-Cola,
Nike and Dell.